Investigations of filovirus propagation and cellular defense mechanisms against filoviruses in the reservoir host Rousettus aegyptiacus and other fruit bat species
Investigations of filovirus propagation and cellular defense mechanisms against filoviruses in the reservoir host Rousettus aegyptiacus and other fruit bat species
批准号:
226375906
负责人:
Professor Dr. Stephan Becker
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2015-12-31
中文摘要
马尔堡病毒(MARV)和埃博拉病毒(EBOV)都是丝状病毒科的成员,它们驻留在中非的果蝠中,并在人群中引起零星暴发。人感染丝状病毒可导致病死率高的严重出血热,而作为丝状病毒天然宿主的果蝠似乎没有表现出症状。人体内丝状病毒的主要靶细胞是单核细胞、巨噬细胞和树突状细胞。丝状病毒在先天免疫和适应性免疫中的功能受损导致大量细胞因子分泌和丝状病毒引起的疾病的严重程度。目前尚不清楚果蝠来源的单核细胞、巨噬细胞和树突状细胞是否易受丝状病毒感染,以及它们在感染过程中是否起决定性作用。不同的果蝠物种被描述为EBOV和MARV的潜在宿主。在锤头蝠、法兰奎特肩章果蝠和小颈果蝠三种不同果蝠中检测到ebov特异性抗体。在另一种果蝠——埃及果蝠中发现了MARV特异性RNA和抗体,这是迄今为止唯一分离出传染性MARV的物种。MARV和EBOV在埃及果蝠的细胞中增殖不均匀。因此,我们假设病毒特异性差异决定了它们在特定果蝠细胞中复制的能力。i型干扰素(IFN)系统是针对病毒的第一个有效的细胞防御机制,大多数病毒开发了抑制IFN系统以允许病毒复制的对抗策略。病毒蛋白抑制IFN反应能力的物种特异性差异可能与病毒对新宿主的适应有关。丝状病毒IFN拮抗剂(VP35、VP40和VP24)如何控制果蝠的IFN系统,以及物种特异性差异是否有助于降低病毒在宿主体内的致病性,目前尚不清楚。综上所述,就其复制或限制丝状病毒的能力而言,储存库宿主和受体物种之间的差异知之甚少。然而,这些差异对于一方面了解线状病毒在人类中的致病性,另一方面了解蝙蝠的免疫系统是很重要的,蝙蝠的免疫系统能够传播许多导致人类严重疾病的病毒。我们希望研究(i)果蝠的永生化细胞和原代细胞对丝状病毒感染的反应,(ii)不同病毒株在果蝠细胞中的繁殖,(iii)果蝠衍生细胞对丝状病毒的细胞防御机制。
英文摘要
Marburg virus (MARV) and Ebola viruses (EBOV), both members of the family Filoviridae, reside in fruit bats in Central Africa and cause sporadic outbreaks in the human population. Filoviral infections in humans lead to a severe hemorrhagic fever with high case-fatality rates, in contrast, fruit bats, the natural reservoir for filoviruses do not seem to show symptoms. Primary target cells for filoviruses in humans are monocytes, macrophages and dendritic cells. Impairment of their function in innate and adaptive immunity leads to massive cytokine secretion and severity of the disease caused by filoviruses. Currently it is not known whether fruit bat derived monocytes, macrophages and dendritic cells are susceptible to filovirus infection and if they play a decisive role during the course of infection.Distinct fruit bat species are described as the potential reservoir for EBOV and MARV. EBOVspecific antibodies were detected in three different fruit bat species: the Hammer-headed Bat, Franquet’s Epauletted Fruit Bat and Little Collared Fruit Bat. MARV-specific RNA and antibodies were found in another fruit bat species the Egyptian Fruit Bat and so far, this is the only species from which infectious MARV has been isolated. MARV and EBOV proliferate unequally well in cells from the Egyptian Fruit Bat. Therefore we presume that virus-specific differences determine their capability to replicate in a specific fruit bat cell.The type-I-interferon (IFN) system is the first effective cellular defense mechanism against viruses and most viruses developed counter strategies that inhibit the IFN system to allow viral replication. Species-specific differences in the capability of viral proteins to inhibit the IFN response can be relevant for the adaptation of viruses to a new host. Nothing is known so far on how the filoviral IFN antagonists (VP35, VP40 and VP24) control the IFN system of fruit bats and whether speciesspecific differences might contribute to reduced pathogenicity of the virus in the reservoir host in comparison to the recipient host.Taken together, very little is known about the differences between reservoir host and recipient species in terms of their ability to replicate or restrict filoviruses. These differences, however, are important to understand on the one hand the pathogenicity of filoviruses in humans and on the other hand the immune system of bats that are able to propagate many viruses that induce severe diseases in men. We would like to investigate (i) the response of immortalized and primary cells of fruit bats to filovirus infection, (ii) the propagation of different virus strains in fruit bat cells, (iii) cellular defense mechanisms against filoviruses in fruit bat derived cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Budding of Marburg virus
-
批准号:13165805
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2005
-
负责人:Professor Dr. Stephan Becker
-
依托单位:
Targeting immunophilin- and MAPK-associated pathways to inhibit MERS-CoV replication and prevent lung injury
-
批准号:319808243
-
项目类别:Clinical Research Units
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Stephan Becker
-
依托单位:
海外基金